Israel - English - Ministry of Health

astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - nasal spray, suspension - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - influenza virus (nh) a/brisbane/10/2007 (h3n2)-like strain - injection, suspension - 15 mcg haemagglutinin/0.5 ml

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson pte. ltd. - influenza virus a/california/7/2009 (h1n1)- like strain - injection, suspension - 15mcg haemagglutinin /0.5 ml

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - influenza virus (nh) a/california/7/2009 (h1n1)pdm09 - like strain - injection - 15 mcg haemagglutinin/0.5 ml

Singapore - English - HSA (Health Sciences Authority)

united italian trading corporation (private) limited - influenza virus (nh) a/brisbane/59/2007(ivr-148)(h1n1) - injection - 15 mcg haemagglutinin/0.5 ml

Canada - English - Health Canada

aventis pasteur inc. - influenza virus vaccine - liquid - 45mcg - influenza virus vaccine 45mcg - vaccines

Canada - English - Health Canada

sanofi pasteur limited - a/panama/2007/99 (h3n2) -like strain; a/new caledonia/20/99(h1n1)-like strain; b/hong kong/1434/2002-like strain - suspension - 15mcg; 15mcg; 15mcg - a/panama/2007/99 (h3n2) -like strain 15mcg; a/new caledonia/20/99(h1n1)-like strain 15mcg; b/hong kong/1434/2002-like strain 15mcg - vaccines

Canada - English - Health Canada

sanofi pasteur limited - haemagglutinin-strain a (h1n1); haemagglutinin-strain a (h3n2); haemagglutinin-strain b - suspension - 9mcg; 9mcg; 9mcg - haemagglutinin-strain a (h1n1) 9mcg; haemagglutinin-strain a (h3n2) 9mcg; haemagglutinin-strain b 9mcg - vaccines

Canada - English - Health Canada

sanofi pasteur limited - haemagglutinin-strain a (h1n1); haemagglutinin-strain a (h3n2); haemagglutinin-strain b - suspension - 15mcg; 15mcg; 15mcg - haemagglutinin-strain a (h1n1) 15mcg; haemagglutinin-strain a (h3n2) 15mcg; haemagglutinin-strain b 15mcg - vaccines

Canada - English - Health Canada

sanofi pasteur inc - haemagglutinin-strain a (h1n1); haemagglutinin-strain a (h3n2); haemagglutinin-strain b - suspension - 7.5mcg; 7.5mcg; 7.5mcg - haemagglutinin-strain a (h1n1) 7.5mcg; haemagglutinin-strain a (h3n2) 7.5mcg; haemagglutinin-strain b 7.5mcg - vaccines